Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Total 13F shares
-
68,874,803
-
Share change
-
+4,085,970
-
Total reported value
-
$2,270,930,799
-
Put/Call ratio
-
114%
-
Price per share
-
$32.96
-
Number of holders
-
171
-
Value change
-
-$120,437,383
-
Number of buys
-
98
-
Number of sells
-
102
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q3 2021
As of 30 Sep 2021 Apellis Pharmaceuticals, Inc. - Common Stock (APLS) had 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 68,874,803 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, JENNISON ASSOCIATES LLC, CITADEL ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, and FMR LLC.
This table shows 172 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.